M&A Archives - Page 185 of 448

2 minute read

Michael Kors and Jimmy Choo To Join The House Of Coach and Kate Spade, But It’s Not All Rosy: Analysts Weigh In

August 11, 1:24 PM

On Thursday, Tapestry, Inc (NYSE: TPR) disclosed plans to acquire Capri Holdings Limited (NYSE: CPRI) for $57.00 per share in cash for a total enterprise value of

CPRI

2 minute read

U.S. Global Investors, Inc. Announces That It Repurchased 61,989 Of Its Own Shares In July 2023, At A Net Cost Of Over $196,000

By Happy Mohamed

August 11, 10:34 AM

U.S. Global Investors, Inc. (NASDAQ: GROW) (the "Company"), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, today is pleased to announce

GROW

1 minute read

Amcor Boosts Presence In India Through Phoenix Flexibles Buyout

By Lekha Gupta

August 11, 10:26 AM

Amcor PLC (NYSE: AMCR) disclosed inking an agreement to acquire Phoenix Flexibles for an undisclosed amount, to boost its footprints in the

AMCR

1 minute read

Arco Platform Agrees To Go Private Via $1.5B Merger Deal

By Shivani Kumaresan

August 11, 6:11 AM

Arco Platform Ltd (NASDAQ: ARCE) has entered into an

ARCE

1 minute read

Cano Health Stock Plummets After-Hours Following Dismal Q2 Results, Seeks Strategic Options Inducing Sale

By Ryan Gustafson

August 10, 5:16 PM

Cano Health, Inc. (NYSE: CANO) shares are tumbling after-hours on Thursday after reporting worse-than-expected

CANO

3 minute read

Ameresco Announces Acquisition Of Joint Forces Training Base-Los Alamitos Microgrid Asset; Over 54MW To Be Added To Energy Asset Portfolio; No Financial Terms Disclosed

By Happy Mohamed

August 10, 5:07 PM

Large-scale microgrid project to provide Army and California National Guard with 100% backup power Over 54MW to be added to Energy Asset Portfolio Continues Ameresco's track record of operating solar and

AMRC

4 minute read

TriSalus Life Sciences Completes Merger With MedTech Acquisition Corporation

By Happy Mohamed

August 10, 4:54 PM

Advances TriSalus' Platform Focused on Improving Outcomes for Patients with Liver and Pancreatic Cancer Expected to Advance Technology Development and Sales Growth Advancing SD-101 Into Phase 2 Clinical Trial in

MTAC